Invasive Candida Infections in Pediatric Patients Treated on the Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium

被引：4

作者：

Burke, Michael J. ^{[1
]}

Brown, Patrick ^{[2
]}

Gore, Lia ^{[3
]}

Sposto, Richard ^{[4
]}

Bhojwani, Deepa ^{[5
]}

Chang, Bill H. ^{[6
]}

Dubois, Steven G. ^{[7
]}

Gaynon, Paul S. ^{[4
]}

Glade-Bender, Julia ^{[8
]}

Heym, Kenneth Matthew ^{[9
]}

Sulis, Maria Luisa ^{[8
]}

Pollard, Jessica A. ^{[10
]}

Verma, Anupam ^{[11
]}

Van Huynh ^{[12
]}

机构：

[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[3] Univ Colorado, Ctr Canc, Aurora, CO USA

[4] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA

[5] St Jude Childrens Res Hosp, Memphis, TN 38105 USA

[6] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[7] Univ Calif San Francisco, Sch Med, San Francisco, CA USA

[8] Columbia Univ, New York, NY USA

[9] Cook Childrens Hosp, Ft Worth, TX USA

[10] Maine Childrens Canc Program, Scarborough, ME USA

[11] Univ Utah, Primary Childrens Med Ctr, Salt Lake City, UT USA

[12] Childrens Hosp Orange Cty, Orange, NJ USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

10.1182/blood.V124.21.3650.3650

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 41 条

[21] A Phase I Study Of AC220 (Quizartinib) In Combination With Cytarabine and Etoposide In Relapsed/Refractory Childhood ALL and AML: A Therapeutic Advances In Childhood Leukemia & Lymphoma (TACL) Study
Cooper, Todd Michael
Malvar, Jemily
Cassar, Jeannette
Eckroth, Elena
Sposto, Richard
Gaynon, Paul
Dubois, Steven
Gore, Lia
Macy, Margaret E.
August, Keith J.
Thomson, Blythe
Oesterheld, Javier
Gammon, Guy
Magoon, Daniel
Annesley, Colleen E.
Brown, Patrick
BLOOD, 2013, 122 (21)
[22] Vincristine Sulfate Liposome Injection (VSLI, Marqibo®) in Combination with UK ALL-R3 Induction Chemotherapy for Children, Adolescents and Young Adults with Relapsed Acute Lymphoblastic Leukemia (ALL): A Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium Trial
Shah, Nirali N.
Schafer, Eric S.
Heym, Kenneth Matthew
Place, Andrew E.
Burns, Melissa A.
Gossai, Nathan
Shaw, Peter
Burke, Michael J.
Chang, Bill H.
Hermiston, Michelle L.
Schore, Reuven J.
Rushing, Teresa
Jarosinski, Paul F.
Sposto, Richard
Florendo, Ellynore
Malvar, Jemily
Chi, Yueh-Yun
Whitlock, James A.
Silverman, Lewis B.
Bhojwani, Deepa
Wayne, Alan S.
BLOOD, 2021, 138
[23] Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
Messinger, Yoav H.
Gaynon, Paul S.
Sposto, Richard
van der Giessen, Jeannette
Eckroth, Elena
Malvar, Jemily
Bostrom, Bruce C.
BLOOD, 2012, 120 (02) : 285 - 290
[24] Vincristine Sulfate Liposome Injection with Combination Chemotherapy for Children, Adolescents, and Young Adults with Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial
Shah, Nirali N.
Schafer, Eric S.
Chi, Yueh-Yun
Malvar, Jemily
Heym, Kenneth M.
Place, Andrew E.
Burns, Melissa
Chang, Bill H.
Slone, Tamra
Verma, Anupam
Gossai, Nathan
Shaw, Peter H.
Burke, Michael J.
Hermiston, Michelle
Schore, Reuven J.
Cooper, Todd
Pauly, Melinda
Rushing, Teresa
Jarosinski, Paul
Florendo, Ellynore
Yates, Bonnie
Widemann, Brigitte C.
Peer, Cody J.
Figg, William D.
Silverman, Lewis B.
Bhojwani, Deepa
Wayne, Alan S.
PEDIATRIC BLOOD & CANCER, 2025, 72 (05)
[25] Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium
Schafer, Eric S.
Rushing, Teresa
Crews, Kristine R.
Annesley, Colleen
Colace, Susan, I
Kaiser, Nicole
Pommert, Lauren
Ramsey, Laura B.
Sabnis, Himalee S.
Wong, Kenneth
Chang, Bill H.
Cooper, Todd M.
Shah, Nirali N.
Rheingold, Susan R.
Place, Andrew E.
Chi, Yueh-Yun
Bhojwani, Deepa
Wayne, Alan S.
Bernhardt, M. Brooke
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (11):
[26] Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study
N. Gossai
D. Bhojwani
E. S. Schafer
B. H. Chang
L. Pommert
A. Verma
J. Malvar
Y. Y. Chi
J. Hitzler
M. J. Burke
K. R. Rabin
Leukemia, 2023, 37 : 1138 - 1140
[27] Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study
Gossai, N.
Bhojwani, D.
Schafer, E. S.
Chang, B. H.
Pommert, L.
Verma, A.
Malvar, J.
Chi, Y. Y.
Hitzler, J.
Burke, M. J.
Rabin, K. R.
LEUKEMIA, 2023, 37 (05) : 1138 - 1140
[28] Re-Induction Outcome for Pediatric Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Therapeutic Advances in Childhood Leukemia Consortium
Sun, Weili
Malvar, Jemily
Sposto, Richard
Verma, Anupam
Wilkes, Jennifer J.
Dennis, Robyn M.
Heym, Kenneth Matthew
Eckroth, Elena
Vandergiesse, Jeannette
Gaynon, Paul S.
Wayne, Alan S.
Whitlock, James A.
BLOOD, 2015, 126 (23)
[29] Bortezomib Combined with VXLD Chemotherapy Is Highly Effective In Advanced B-Lineage Acute Lymphoblastic Leukemia Allowing Early Study Termination Due to Efficacy. A Therapeutic Advances in Childhood Leukemia (TACL) Consortium Phase II Study
Messinger, Yoav H.
Gaynon, Paul
Sposto, Richard
van der Giessen, Jeannette
Eckroth, Elena
Malvar, Jemily
Bostrom, Bruce C.
BLOOD, 2011, 118 (21) : 114 - 115
[30] Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group
Osumi, Tomoo
Mori, Tetsuya
Fujita, Naoto
Saito, Akiko M.
Nakazawa, Atsuko
Tsurusawa, Masahito
Kobayashi, Ryoji
PEDIATRIC BLOOD & CANCER, 2016, 63 (10) : 1794 - 1799

← 1 2 3 4 5 →